Navigation Links
Healthrageous, United BioSource And Boehringer Ingelheim Launch SMART Digital Diabetes Study
Date:7/16/2013

," said Rick Lee, President and CEO, Healthrageous. "We are delighted to be working with Boehringer Ingelheim and UBC on this first-of-its-kind evaluation of the promise that digital technology holds in stemming the Type 2 diabetes epidemic."

"Boehringer Ingelheim is committed to innovation in diabetes treatment and strives for solutions that offer a 'beyond pill' approach in health care," said Klaus Wilgenbus, SVP, PM, Business Development, Licensing & Strategy at Boehringer Ingelheim. "As part of our ongoing collaboration with Healthrageous, this project adds nicely to our goal to provide and develop solutions for patients and their families that contribute to a more holistic way of diabetes treatment."

About Healthrageous
Healthrageous, Inc. is an Accountable Health company that supports individual journeys to prevent and self-manage chronic health conditions via the web and a mobile app. It achieves superior engagement through its proprietary platform that incorporates personalized goal setting, health journey maps with gaming dynamics, timely biometric feedback and interactive digital coaching. The digital coach leverages multiple tools such as inspirational messages, recognition and incentives, challenges, social networking, trackers and reminders, and interactive educational content.

The company's solutions are based on technologies developed at the Center for Connected Health, a division of Partners HealthCare, founded by Brigham and Women's Hospital and Massachusetts General Hospital, teaching affiliates of Harvard Medical School. Connect: www.healthrageous.com, Twitter and L
'/>"/>

SOURCE Healthrageous, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. ACLS Online Renewal Course from United Medical Education Now Features Newly-Updated Course Materials
2. United States losing ground to other countries in health outcomes
3. SPIE on global team proposing International Year of Light at United Nations
4. UnitedHealth Group grants more than $1 million for the heart of New Ulm project
5. Celladon Corporation Receives Notice of Allowance from United States Patent and Trademark Office
6. Could cap and trade for water solve problems facing the United States largest rivers?
7. Culturally sensitive research in United Arab Emirates pinpoints indoor air quality risks
8. Syracuse University study finds autumn advantage for invasive plants in eastern United States
9. Clue, a Berlin Startup Founded By a Woman, Launches An Intelligent Tracking App That Decodes a Womans Fertility Cycle
10. Fund launched to seed new thinking in sustaining the future of health
11. Xyngular Announces the Launch of its New Xyng Enhanced Formula
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2014)... 6, 2014 - Insilico Medicine, Inc, a Baltimore-based ... age related diseases announced a research collaboration with ... Champions Oncology, Inc (OTC: CSBR). , "There are ... medicine, but Champions Oncology,s TumorGraft technology is unique ... chemotherapy regimen experimentally generating vast amounts of valuable ...
(Date:11/5/2014)... Kelly Redmond has dedicated his career to understanding ... a general audience. , As deputy director and ... at Nevada,s Desert Research Institute, Redmond has more ... application and dissemination of climate data to the ... Meeting in San Francisco on December 15-19, 2014 ...
(Date:11/4/2014)... LAKE CITY, Nov. 5, 2014 – University of Utah ... enzymes to help jet fuel produce electricity without needing ... be used to power portable electronics, off-grid power and ... online today in the American Chemical Society journal ... electricity through a chemical reaction between a fuel and ...
Breaking Biology News(10 mins):Insilico Medicine, Inc announces research collaboration with Champions Oncology, Inc 2Nevada climatologist to be honored at AGU Fall Meeting for lifetime of public outreach 2Jet-fueled electricity at room temperature 2
... for the first time, how a potted plant,s roots are arranged ... be presented at the Society for Experimental Biology meeting on 30th ... makes plants grow over 40% larger. From their 3-D ... their roots to the pot,s walls. It is likely that the ...
... new batch of Geology papers posted online ... asynchrony; oceanic crust; sand budgets; the Alpine fault,s seismic ... weathering in the Critical Zone; giant wave ripples; the ... network; and soils as ledgers recording transactions of energy ...
... apart DNA that bears certain signature sequences is a defense ... can be a powerful research tool. With a newly discovered ... a targeted method of slicing DNA that they say can ... lab. Tools that snip apart DNA strands in defined ...
Cached Biology News:Sandy beaches, hydrocarbon reservoirs, tectonic tilting: It's all about geology 2Sandy beaches, hydrocarbon reservoirs, tectonic tilting: It's all about geology 3Sandy beaches, hydrocarbon reservoirs, tectonic tilting: It's all about geology 4Sandy beaches, hydrocarbon reservoirs, tectonic tilting: It's all about geology 5Sandy beaches, hydrocarbon reservoirs, tectonic tilting: It's all about geology 6Sandy beaches, hydrocarbon reservoirs, tectonic tilting: It's all about geology 7Sandy beaches, hydrocarbon reservoirs, tectonic tilting: It's all about geology 8Sandy beaches, hydrocarbon reservoirs, tectonic tilting: It's all about geology 9Sandy beaches, hydrocarbon reservoirs, tectonic tilting: It's all about geology 10Programmable RNA complex could speed genome editing in the lab 2Programmable RNA complex could speed genome editing in the lab 3
(Date:11/22/2014)... , November 21, 2014 ... wechselt als Chief Commercial Officer zu KLOX    ... der Unternehmensentwicklung und Chief Financial Officer bestellt    ... mit der Vermarktung seines jüngst zugelassenen Behandlungssystems zur Wundheilung ... ("KLOX" bzw. das "Unternehmen") ist sehr erfreut, die folgenden ...
(Date:11/21/2014)... 20, 2014 Offering a complete line ... Entris Balance promotion . The Sartorius Entris Balance is ... high accuracy, and easy-to-maintain balance entry level balance. , ... was designed to help customer’s bridge the gap between ... that is very durable. Sartorius is the second biggest ...
(Date:11/21/2014)... NY (PRWEB) November 20, 2014 The ... now available as an open access journal featuring the ... infrared fluorescent proteins to preserve photoresponsiveness in the retina ... Two-color fluorescent in situ hybridization using chromogenic substrates in ... for DNA, RNA, and protein electrophoresis , ...
(Date:11/21/2014)... 2014 2014 Deep Research Report ... in-depth research report on the transformer market. The ... application, and industry chain structure as well as ... analysis, including China’s domestic market as well as ... situation analysis. The report also covers information on ...
Breaking Biology Technology:KLOX Technologies meldet Neubesetzung von Führungspositionen 2KLOX Technologies meldet Neubesetzung von Führungspositionen 3KLOX Technologies meldet Neubesetzung von Führungspositionen 4KLOX Technologies meldet Neubesetzung von Führungspositionen 5Pipette.com Announces an Extension on the Sartorius Entris Balance Promotion to the End of 2014 2BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 2BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 3International Transformer Industry - Analysis on Applications, Development & Forecasts Now Available at ReportsnReports.com 2International Transformer Industry - Analysis on Applications, Development & Forecasts Now Available at ReportsnReports.com 3
... /PRNewswire-FirstCall/ - MIGENIX Inc.,(TSX: MGI; OTC: MGIFF), ... reports financial results for the three months ... its programs., UPDATE ON DRUG DEVELOPMENT ... cationic peptide;,prevention of catheter-related infections): A pivotal ...
... a Planned Phase II Study of ... Sclerosis, COPENHAGEN, Denmark, December 13 Genmab A/S,(OMX: ... study of,ofatumumab (HuMax-CD20(R)) for the treatment of relapsing remitting,multiple ... study which will be conducted under Genmab,s collaboration with,GlaxoSmithKline ...
... SAN FRANCISCO, Calif., Dec. 13 Anesiva,Inc. (Nasdaq: ... a common stock offering,of 11,111,111 shares of its ... discount to the closing bid price on December ... before deducting underwriting,discounts and commissions (approximately $50 million ...
Cached Biology Technology:MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 2MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 3MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 4MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 5MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 6MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 7MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 8MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 9MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 10MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 11MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 12MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 13MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 14MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 15MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 16MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 17MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 18Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis 2Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis 3Anesiva Raises $45 Million in Common Stock Offering 2
... α chain (human), clone 41D ... Immunogen : Native clusterin purified from ... 7.4, 0.15M NaCl and 0.05% sodium ... RIPA lysates from HeLa cells or ...
Rabbit polyclonal to Methionine Aminopeptidase 2 ( Abpromise for all tested applications). entrezGeneID: 10988 SwissProtID: P50579...
Chlamydia pneumoniae (TWAR)...
Mouse anti-Insulin-Like-3 Class: Antibody Product Group: Adipokine and Obesity related...
Biology Products: